Autoimmune Complications in Hematologic Neoplasms. [PDF]
Cancers (Basel), 2021 Autoimmune cytopenias (AICy) and autoimmune diseases (AID) can complicate both lymphoid and myeloid neoplasms, and often represent a diagnostic and therapeutic challenge. While autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP) are well known, other rarer AICy (autoimmune neutropenia, aplastic anemia, and pure red cell aplasia) and ...
Barcellini W, Giannotta JA, Fattizzo B.
europepmc +4 more sources
Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment [PDF]
Cell Communication and Signaling, 2023 In clinical diagnosis, the capability of exosomes to serve as biomarkers is one of the most important biological functions of exosomes. The superior stability of exosome biomarkers makes them superior to those isolated from traditional samples such as ...
Faride Nam Avar Jahromi +2 more
doaj +2 more sources
Association of hydralazine use with risk of hematologic neoplasms in patients with hypertension: A nationwide population-based cohort study in Taiwan. [PDF]
PLoS MedicineBackgroundOnco-hypertension recognizes well-controlled blood pressure as a favorable prognostic factor for survival in patients with hypertension and solid tumors, including hematologic neoplasms.
Li-Tzu Wang +6 more
doaj +2 more sources
Care for patients with hematologic neoplasms: contextual analysis resulting from a scoping review [PDF]
Revista Brasileira de EnfermagemObjective: To analyze and map evidence in the literature on the contexts in which care for patients with hematologic neoplasms occurs within health services.
Isabelle Campos de Azevedo +5 more
doaj +2 more sources
Cutaneous Hematologic Neoplasms in Children: Overview and Update [PDF]
DermatopathologyCutaneous hematologic neoplasms in children are relatively rare and encompass a wide range of lymphoproliferative and myeloproliferative disorders.
Philippe Drabent +4 more
doaj +2 more sources
A potential prognostic marker for hematologic neoplasms: CD58 [PDF]
Frontiers in OncologyCD58 is a glycoprotein receptor widely distributed on histiocytes that binds to CD2, that takes part in constituting the Immunological Synapses (IS) and activating T/NK cells.
Jiajia Cao +5 more
doaj +2 more sources
Dermatological manifestations of hematologic neoplasms. Part I: secondary specific skin lesions [PDF]
Anais Brasileiros de Dermatologia, 2023 Cutaneous manifestations occur during the course of hematologic malignancies and precede, follow, or are late events in relation to the diagnosis. They result from paraneoplastic phenomena, tumor infiltrations, and immunosuppression resulting from the ...
Patricia Karla de Souza +3 more
doaj +2 more sources
The role of JAK2 abnormalities in hematologic neoplasms.
Hematology Reports, 2009 In 2005, an activating mutation in the Janus kinase 2 (JAK2) was identified in a significant proportion of patients with myeloproliferative neoplasms, mainly polycythemia vera, essential thrombocythemia and primary myelofibrosis.
Mohammed Khalid Alabdulaali
doaj +3 more sources
EBF1, PAX5, and MYC: regulation on B cell development and association with hematologic neoplasms [PDF]
Frontiers in ImmunologyLi L, Zhang D, Cao X.
exaly +2 more sources
Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24 900 Survivors [PDF]
JNCI Cancer Spectrum, 2020 Michael Milano +2 more
exaly +2 more sources